Apellis Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Apellis Pharmaceuticals, Inc.
CIK #0001492422
EDGAR Form CIK 2011 - 2025
10-K [0001492422]
10-Q [0001492422]
3 [0001492422]
4 [0001492422]
5 [0001492422]
8-K [0001492422]
D [0001492422]
SC 13G [0001492422]
Form 13D/13G Filer Form 13D/13G Subject Filed
Deep Track Capital LP Apellis Pharmaceuticals Inc [2025-05-16]
Morgan Stanley Apellis Pharmaceuticals Inc [2025-02-03]
Deep Track Capital LP Apellis Pharmaceuticals Inc [2024-11-22]
BlackRock Inc Apellis Pharmaceuticals Inc [2024-11-08]
BlackRock Inc Apellis Pharmaceuticals Inc [2024-10-18]
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2024-02-14]
EcoR1 Capital LLC Apellis Pharmaceuticals Inc [2023-07-18]
T Rowe Price Investment Management Inc Apellis Pharmaceuticals Inc [2023-02-14]
Price T Rowe Associates Inc /MD/ Apellis Pharmaceuticals Inc [2022-02-14]
Avoro Capital Advisors LLC Apellis Pharmaceuticals Inc [2022-02-11]
View All
Form 3/4/5 Subject 2011 - 2025
Apellis Pharmaceuticals, Inc.
Watson David O.
Francois Cedric
Chopas James George
Deschatelets Pascal
Baumal Caroline
DeLong Mark Jeffrey
Sullivan Timothy Eugene
Nicholson Nur
Boucher Kelley
View All
Terms | Privacy | Guide
tony@aum13f.com